http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101338473-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
| filingDate | 2011-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101338473-B1 |
| titleOfInvention | Pharmaceutical composition for the prevention or treatment of cancer comprising microvesicles ADMA15 as an active ingredient |
| abstract | The present invention relates to a pharmaceutical composition for preventing or treating cancer comprising microvesicular ADAM15 as an active ingredient. According to the present invention, it is possible to provide a microvesicle ADAM15 composition from human immune cells, and to provide new cellular regulatory mechanisms mediated by ADAM proteins through the functional study of microvesicle ADAM15. In addition, the present invention can provide a novel anticancer agent using microvesicles ADAM15 to inhibit the adhesion, proliferation and migration of tumor cells. |
| priorityDate | 2011-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 400.